Health care charges for patients with ocular hypertension or primary open-angle glaucoma

Louis R Pasquale1, Margarita Dolgitser, Jeffrey N Wentzloff

  • 1Glaucoma Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.

Ophthalmology
|August 25, 2007
PubMed

Insights

Patients with primary open-angle glaucoma (POAG) incurred higher healthcare costs than those with ocular hypertension (OH). Factors like age, gender, and comorbidities significantly impact these charges, highlighting the economic burden of these eye conditions.

Area of Science:

  • Ophthalmology
  • Health Economics
  • Public Health

Background:

  • Ocular hypertension (OH) and primary open-angle glaucoma (POAG) are significant causes of vision impairment.
  • Understanding the economic burden associated with these conditions is crucial for healthcare planning and resource allocation.

Purpose of the Study:

  • To determine the total and condition-related direct healthcare charges for patients with OH and POAG.
  • To identify key factors influencing these healthcare expenditures.

Main Methods:

  • Retrospective cohort study utilizing a large, nationally representative health plan database (PharMetrics).
  • Inclusion of 36,767 patients with OH and 72,412 patients with POAG with at least one year of continuous enrollment between 1998-2005.
  • Multivariate linear regression models were employed to analyze first-year total and condition-related healthcare charges, adjusting for various covariates.

Main Results:

  • Patients with POAG had significantly higher adjusted total ($2070) and condition-related ($556) healthcare charges compared to OH patients ($1990 and $322, respectively).
  • Female gender and older age were associated with higher total healthcare charges, but not strongly with condition-related charges.
  • Ocular comorbidities such as cataracts, diabetic retinopathy, and blindness substantially increased both total and condition-related healthcare charges (P<0.0001).

Conclusions:

  • Healthcare charges for patients with OH and POAG are substantial.
  • Factors including the specific ophthalmic condition (POAG vs. OH), patient demographics, treatment, and presence of comorbidities significantly influence healthcare costs.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...